Nu Skin Enterprises Stock Forecast, Price & News

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Nu Skin Enterprises in the last twelve months. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Nu Skin Enterprises stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NUS, but not buy additional shares or sell existing shares.
View analyst ratings for Nu Skin Enterprises or view top-rated stocks.

3 analysts have issued 1 year price objectives for Nu Skin Enterprises' stock. Their NUS stock forecasts range from $49.00 to $75.00. On average, they anticipate Nu Skin Enterprises' share price to reach $61.50 in the next year. This suggests a possible upside of 32.3% from the stock's current price.
View analysts' price targets for Nu Skin Enterprises or view top-rated stocks among Wall Street analysts.

Nu Skin Enterprises' stock was trading at $50.75 on January 1st, 2022. Since then, NUS shares have decreased by 8.4% and is now trading at $46.48.
View the best growth stocks for 2022 here.

Nu Skin Enterprises saw a decrease in short interest in the month of May. As of May 31st, there was short interest totaling 3,660,000 shares, a decrease of 22.5% from the May 15th total of 4,720,000 shares. Based on an average trading volume of 604,100 shares, the short-interest ratio is presently 6.1 days. Approximately 7.5% of the shares of the company are sold short.
View Nu Skin Enterprises' Short Interest.

Nu Skin Enterprises is scheduled to release its next quarterly earnings announcement on Wednesday, August 3rd 2022.
View our earnings forecast for Nu Skin Enterprises.

Nu Skin Enterprises, Inc. (NYSE:NUS) announced its quarterly earnings data on Wednesday, May, 4th. The company reported $0.76 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.73 by $0.03. The firm had revenue of $604.90 million for the quarter, compared to analysts' expectations of $579.70 million. Nu Skin Enterprises had a net margin of 5.28% and a trailing twelve-month return on equity of 22.05%. The business's quarterly revenue was down 10.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.91 earnings per share.
View Nu Skin Enterprises' earnings history.

Nu Skin Enterprises announced a quarterly dividend on Wednesday, May 4th. Investors of record on Friday, May 27th will be given a dividend of $0.385 per share on Wednesday, June 8th. This represents a $1.54 annualized dividend and a yield of 3.31%. The ex-dividend date is Thursday, May 26th.
View Nu Skin Enterprises' dividend history.

Nu Skin Enterprises(NYSE:NUS) pays an annual dividend of $1.54 per share and currently has a dividend yield of 3.36%. Nu Skin Enterprises has been increasing its dividend for 23 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Nu Skin Enterprises is 57.04%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Nu Skin Enterprises will have a dividend payout ratio of 37.65% next year. This indicates that Nu Skin Enterprises will be able to sustain or increase its dividend.
View Nu Skin Enterprises' dividend history.

Nu Skin Enterprises updated its FY 2022 earnings guidance on Monday, May, 16th. The company provided earnings per share (EPS) guidance of $3.60-$3.90 for the period, compared to the consensus earnings per share estimate of $4.21. The company issued revenue guidance of $2.51 billion-$2.62 billion, compared to the consensus revenue estimate of $2.70 billion.

72 employees have rated Nu Skin Enterprises CEO Ritch Wood on Glassdoor.com. Ritch Wood has an approval rating of 91% among Nu Skin Enterprises' employees. This puts Ritch Wood in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Nu Skin Enterprises include Estée Lauder Companies (EL), Prestige Consumer Healthcare (PBH), Herbalife Nutrition (HLF), Inter Parfums (IPAR), Medifast (MED), USANA Health Sciences (USNA), Veru (VERU), Revlon (REV) and Nature's Sunshine Products (NATR).
View all of NUS's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Nu Skin Enterprises investors own include Alibaba Group (BABA), General Electric (GE), NVIDIA (NVDA), Marathon Petroleum (MPC), Gilead Sciences (GILD), Alphabet (GOOG), Tesla (TSLA), Herbalife Nutrition (HLF), Mastercard (MA) and Netflix (NFLX).

Nu Skin Enterprises trades on the New York Stock Exchange (NYSE) under the ticker symbol "NUS."

Nu Skin Enterprises' stock is owned by a number of retail and institutional investors. Top institutional investors include State Street Corp (13.09%), Vanguard Group Inc. (12.04%), BlackRock Inc. (11.62%), Wellington Management Group LLP (7.43%), Renaissance Technologies LLC (5.36%) and Dimensional Fund Advisors LP (3.43%). Company insiders that own Nu Skin Enterprises stock include Andrew D Lipman, D Matthew Dorny, Foulis Greg, James D Thomas, Jeffrey Clark Bettinger, Joseph Y Chang, Mark H Lawrence, Ritch N Wood, Ryan S Napierski and Steven Lund.
View institutional ownership trends for Nu Skin Enterprises.

NUS stock was sold by a variety of institutional investors in the last quarter, including Charles Schwab Investment Management Inc., Wellington Management Group LLP, Ergoteles LLC, UBS Group AG, Acadian Asset Management LLC, Allianz Asset Management GmbH, JPMorgan Chase & Co., and Mirabella Financial Services LLP. Company insiders that have sold Nu Skin Enterprises company stock in the last two years include Andrew D Lipman, D Matthew Dorny, James D Thomas, Jeffrey Clark Bettinger, Joseph Y Chang, Mark H Lawrence, Ritch N Wood, Ryan S Napierski, and Steven Lund.
View insider buying and selling activity for Nu Skin Enterprises or view top insider-selling stocks.

NUS stock was purchased by a variety of institutional investors in the last quarter, including State Street Corp, Invesco Ltd., Victory Capital Management Inc., Goldman Sachs Group Inc., PEAK6 Investments LLC, The Manufacturers Life Insurance Company , Cooper Creek Partners Management LLC, and Dimensional Fund Advisors LP.
View insider buying and selling activity for Nu Skin Enterprises or or view top insider-buying stocks.

Shares of NUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of NUS stock can currently be purchased for approximately $46.48.

Nu Skin Enterprises (NYSE:NUS) has a market capitalization of $2.33 billion and generates $2.70 billion in revenue each year. The company earns $147.27 million in net income (profit) each year or $2.699990 on an earnings per share basis.

Nu Skin Enterprises employs 4,600 workers across the globe.

Nu Skin Enterprises' mailing address is 75 WEST CENTER ST, PROVO UT, 84601. The official website for Nu Skin Enterprises is www.nuskinenterprises.com. The company can be reached via phone at (801) 345-1000, via email at [email protected], or via fax at 801-345-5999.